Cycle 3: Biomarkers Development
Sponsor: Alzheimer's Drug Discovery Foundation Deadlines: Letter of Intent: September 30, 2022 Invited Full Proposal: December 2, 2022 Award: The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer's disease and related dementias. This RFP prioritizes biomarkers with a defined context of […]